EDURANT

Janssen Products, LP🇺🇸 United States

FDA Page

Effective Date: Mar 28, 2024
Approval ID: 03880372-2c68-45c6-a53a-f420c49541d6
Products: 0 registered
Version: 23

Regulatory Information

Labeling Type

34391-3

Status

Approved

Full Title

{"br": [null, null, null, null], "sup": ["®", "®"], "#text": "These highlights do not include all the information needed to use EDURANT safely and effectively. See full prescribing information for EDURANT.\n \n \nEDURANT \n (rilpivirine) tablets, for oral use\n \nEDURANT \n PED (rilpivirine) tablets, for oral suspension\n \nInitial U.S. Approval: 2011"}

Quick Stats

Total Products0

Labelers1

Label Sections21

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.